Dynamic phototherapy of age-related macular degeneration with or without antioxidant therapy;La photothérapie dynamique de la dégénérescence maculaire liée à l'âge avec ou sans thérapie aux antioxydants

Canadian Journal of Ophthalmology

Volumn 37, Issue 7, 2002, Pages 399-404

  Scorolli, Lucia ^a,c   Scalinci, Sergio Z ^a   Limoli, Paolo G ^b   Morara, MariaChiara ^a   Vismara, Sabrina ^a   Scorolli, Luigi ^a   Corazza, Daniele ^a   Meduri, Renato ^a  

^a Clinique d'Ophtalmologie   (Italy)

^b Centre d'Étude d'Hypovision   (Italy)

^c Clinica di Ottica Fisiopatologica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; MEMBRANE RECEPTOR; POLYUNSATURATED FATTY ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; ITALY; MALE; OPTOMETRY; PHOTODYNAMIC THERAPY; RANDOMIZED CONTROLLED TRIAL; RETINA; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; VISUAL ACUITY;

EID: 0036973063     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1016/s0008-4182(02)80042-4     Document Type: Article

References (16)

1. Soubrane G, Coscas G. Dégénérescence maculaire liée à l'âge. Rev Prat 1996;46(14):1722-9.
2. Soubrane G, Coscas G, Français C, Koenig F. Occult subretinal new vessels in age-related macular degeneration. Natural history and early laser treatment. Ophthalmology 1990;97(5):649-57.
3. Singerman LJ. Current management of choroidal neovascularization. Ann Ophthalmol 1988;20(11):415-20, 423.
4. Husain D, Kramer M, Kenny AG, Michaud N, Flotte TJ, Gragoudas ES, et al. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment. Invest Ophthamol Vis Sci 1999;40(10): 2322-31.
5. Limoli PG, D'Amato L, Solari R, Gilardi E. Il Centro Studi Ipovisione e la terapia fotodinamica. Ipovisione 2000;1:8-12.
6. Bressler NM, for the TAP Research Group. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) investigation using verteporfin (BPD-MA): baseline characteristics and safety [résumé]. Invest Ophthalmol Vis Sci 1998;39(suppl):S242.
7. Limoli PG, D'Amato L, Giulotto A, Giuberti R. Influenze delle vitamine, minerali e aminoacidi sul sistema neurovisivo. Atti 3° Congresso Nazionale "G.I.S.I.", Roma, 08/ 12/94. Minerva Oftalmol 1999;41(3):115-9.
8. Desmettre T, Mordon S, Soulie S, Devoisselle JM, Weisslinger JM. Liposomes en ophtalmologie: revue de la littérature. J Fr Ophtalmol 1996;19(11):716-31.
9. Schmidt-Erfurth U, Diddens H, Birngruber R, Hasan T. Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates. Br J Cancer 1997;75(1):54-61.
10. Aonuma H, Koide K, Masuda K, Watanabe I. Retinal light damage: protective effect of alpha-tocopherol. Jpn J Ophthalmol 1997;41(3):160-7.
11. Rodriguez de Turco EB, Gordon WC, Bazan NG. Rapid and selective uptake, metabolism, and cellular distribution of docosahexaenoic acid among rod and cone photoreceptor cells in the frog retina. J Neurosci 1990;11:3667-78.
12. Bailey IL, Lovie JE. New design principles for visual acuity letter charts. Am J Optom Physiol Opt 1976;53:740-5.
13. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001;119(10): 1417-36.
14. Magder H. Test for central serous retinopathy. Am J Ophthalmol 1960;49:147-9.
15. Schiavi L, Meduri R, Tabacchi G. Comportamento del senso morfoscopico centrale dopo abbagliamento con luce bianca. Minerva Oftalmol 1967;9(1):1-15.
16. Severin SL. Recovery of visual discrimination after high intensity of flashes of light. Aerosp Med 1961;62:16.